Summary
This feasibility study has shown that the novel technology of AI-led telephone calls using automated voice assistants can be delivered to patients with USHNC with a high level of data capture (95%) and accuracy (89%) when compared to clinicians. Patients on this pathway were highly likely to recommend this novel technology to a friend or family member (NPS average 8 out of 10).